Augmentin Dosing for Acute Diverticulitis
For acute diverticulitis requiring antibiotic therapy, Augmentin (amoxicillin-clavulanate) should be dosed at 875 mg/125 mg orally twice daily for 4-7 days in immunocompetent patients, or 10-14 days in immunocompromised patients. 1, 2
Critical Decision Point: Does This Patient Need Antibiotics?
Most immunocompetent patients with uncomplicated diverticulitis do NOT require antibiotics. 3 Multiple high-quality randomized controlled trials, including the DIABOLO trial with 528 patients, demonstrated that antibiotics neither accelerate recovery nor prevent complications or recurrence in uncomplicated cases. 3
Reserve Antibiotics For:
- Immunocompromised status (corticosteroids, chemotherapy, transplant recipients) 1, 2
- Systemic inflammatory response or sepsis 1, 2
- Age >80 years 1
- Significant comorbidities or frailty 1, 2
- Refractory symptoms or vomiting 1, 2
- Elevated inflammatory markers: CRP >140 mg/L or WBC >15 × 10^9/L 1, 2
- CT findings: fluid collection, longer segment of inflammation, or pericolic gas 1, 2
- Symptoms >5 days duration 1
Specific Augmentin Dosing Regimens
Outpatient Oral Therapy (First-Line When Antibiotics Indicated)
Standard dosing: Augmentin 875 mg/125 mg orally twice daily 4
- This provides appropriate polymicrobial coverage for gram-positive, gram-negative, and anaerobic bacteria commonly involved in colonic infections 1
- Should be taken at the start of meals to enhance clavulanate absorption and minimize gastrointestinal intolerance 4
- Alternative regimen: Ciprofloxacin 500 mg twice daily plus metronidazole 500 mg three times daily 1, 2
Inpatient IV-to-Oral Transition
Initial IV therapy: Amoxicillin-clavulanate 1200 mg IV four times daily for at least 48 hours 3
Transition to oral: Augmentin 625 mg orally three times daily after 48 hours once patient tolerates oral intake 3
- Transition to oral antibiotics should occur as soon as possible to facilitate earlier discharge 3, 1
- Hospital stay is actually shorter (2 vs 3 days) in observation groups compared to antibiotic-treated patients 3, 2
Duration of Therapy
Immunocompetent Patients
- This shorter course is supported by the STOP IT trial demonstrating adequate outcomes with 4 days post-operative therapy in complicated cases with source control 1
Immunocompromised Patients
10-14 days total duration 1, 2
- These patients are at significantly higher risk for progression to complicated diverticulitis and sepsis 1
- Includes patients on corticosteroids, chemotherapy, or immunosuppression for organ transplantation 1
Important Clinical Caveats
Dosing Considerations
- Do NOT substitute two 250 mg/125 mg tablets for one 500 mg/125 mg tablet, as both contain the same amount of clavulanic acid (125 mg) 4
- For patients weighing ≥40 kg, use adult dosing recommendations 4
Monitoring and Follow-Up
- Re-evaluate within 7 days; earlier if clinical condition deteriorates 3, 1
- Watch for warning signs requiring immediate attention: fever >101°F, severe uncontrolled pain, persistent vomiting, inability to eat/drink 1
- Avoid alcohol until at least 48 hours after completing metronidazole (if using combination therapy) to prevent disulfiram-like reactions 1
Common Pitfalls to Avoid
- Overuse of antibiotics in uncomplicated cases without risk factors—this contributes to antibiotic resistance without clinical benefit 3, 1, 5
- Stopping antibiotics early even if symptoms improve—this may lead to incomplete treatment and recurrence 1
- Automatically prescribing 10-14 days for all cases—longer duration is specifically for immunocompromised patients only 1
- Failing to recognize high-risk patients who need closer monitoring despite having uncomplicated disease 2
Outpatient Management Criteria
Augmentin outpatient therapy is appropriate when patients meet ALL of the following: 1, 2
- Able to tolerate oral fluids and medications
- No significant comorbidities or frailty
- Adequate home support
- Temperature <100.4°F
- Pain score <4/10 on visual analogue scale (controlled with acetaminophen only)
- Ability to maintain self-care at pre-illness level
If these criteria are not met, consider inpatient management with IV antibiotics. 1, 2